Overman MJ - Search Results

1

Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.

Overman MJ, Varadhachary GR, Kopetz S, Adinin R, Lin E, Morris JS, Eng C, Abbruzzese JL, Wolff RA. Overman MJ, et al. J Clin Oncol. 2009 Jun 1;27(16):2598-603. doi: 10.1200/JCO.2008.19.7145. Epub 2009 Jan 21. J Clin Oncol. 2009. PMID: 19164203 Clinical Trial.

2

The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma.

Overman MJ, Feng L, Pro B, McLaughlin P, Hess M, Samaniego F, Younes A, Romaguera JE, Hagemeister FB, Kwak L, Cabanillas F, Rodriguez MA, Fayad LE. Overman MJ, et al. Ann Oncol. 2008 Mar;19(3):553-9. doi: 10.1093/annonc/mdm511. Epub 2007 Dec 13. Ann Oncol. 2008. PMID: 18083690 Free article.

3

Second-line chemotherapy use in metastatic colon cancer varies by disease responsiveness.

Politano S, Overman M, Pathak P, Chadha R, Glover K, Chang DZ, Wolff RA, Hoff PM, Abbruzzese J, Eng C, Kopetz S. Politano S, et al. Clin Colorectal Cancer. 2008 Jan;7(1):55-9. doi: 10.3816/CCC.2008.n.008. Clin Colorectal Cancer. 2008. PMID: 18279578

4

Systematic survey of therapeutic trials for metastatic colorectal cancer: room for improvement in the critical pathway.

Kopetz S, Overman M, Chang DZ, Glover KY, Shureiqi I, Wolff RA, Abbruzzese JL, Eng C. Kopetz S, et al. J Clin Oncol. 2008 Apr 20;26(12):2000-5. doi: 10.1200/JCO.2007.13.2407. J Clin Oncol. 2008. PMID: 18421052

5

Phase 1 study of TAS-102 administered once daily on a 5-day-per-week schedule in patients with solid tumors.

Overman MJ, Varadhachary G, Kopetz S, Thomas MB, Fukushima M, Kuwata K, Mita A, Wolff RA, Hoff PM, Xiong H, Abbruzzese JL. Overman MJ, et al. Invest New Drugs. 2008 Oct;26(5):445-54. doi: 10.1007/s10637-008-9142-3. Epub 2008 Jun 5. Invest New Drugs. 2008. PMID: 18528634 Clinical Trial.

6

Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma.

Overman MJ, Kopetz S, Wen S, Hoff PM, Fogelman D, Morris J, Abbruzzese JL, Ajani JA, Wolff RA. Overman MJ, et al. Cancer. 2008 Oct 15;113(8):2038-45. doi: 10.1002/cncr.23822. Cancer. 2008. PMID: 18759326 Free article.

7

Aggressive combined modality therapy for recurrent colorectal cancer involving the duodenum and pancreas: a report of 5 cases.

Overman MJ, Fogelman D, Al-Kali A, Crane CH, Evans D, Abdalla EK, Pisters P, Kopetz S, Eng C, Wolff RA. Overman MJ, et al. Clin Colorectal Cancer. 2008 Sep;7(5):338-42. doi: 10.3816/CCC.2008.n.045. Clin Colorectal Cancer. 2008. PMID: 18794067

8

Phase I clinical study of three times a day oral administration of TAS-102 in patients with solid tumors.

Overman MJ, Kopetz S, Varadhachary G, Fukushima M, Kuwata K, Mita A, Wolff RA, Hoff P, Xiong H, Abbruzzese JL. Overman MJ, et al. Cancer Invest. 2008 Oct;26(8):794-9. doi: 10.1080/07357900802087242. Cancer Invest. 2008. PMID: 18798063 Clinical Trial.

9

Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.

Blazer DG 3rd, Kishi Y, Maru DM, Kopetz S, Chun YS, Overman MJ, Fogelman D, Eng C, Chang DZ, Wang H, Zorzi D, Ribero D, Ellis LM, Glover KY, Wolff RA, Curley SA, Abdalla EK, Vauthey JN. Blazer DG 3rd, et al. Among authors: overman mj. J Clin Oncol. 2008 Nov 20;26(33):5344-51. doi: 10.1200/JCO.2008.17.5299. Epub 2008 Oct 20. J Clin Oncol. 2008. PMID: 18936472

10

Picking the right road for metastatic colorectal cancer patients.

Overman M, Kopetz S. Overman M, et al. Oncology (Williston Park). 2008 Nov 30;22(13):1482-3. Oncology (Williston Park). 2008. PMID: 19227576 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

304 results

Search Page

Filters